Cargando…
Association of high cost sharing and targeted therapy initiation among elderly Medicare patients with metastatic renal cell carcinoma
High out‐of‐pocket costs may limit access to oral therapies covered by patients’ prescription drug benefits. We explored financial barriers to treatment initiation in patients newly diagnosed with metastatic renal cell carcinoma (mRCC) by comparing Medicare Part D patients with low out‐of‐pocket cos...
Autores principales: | Li, Pengxiang, Wong, Yu‐Ning, Jahnke, Jordan, Pettit, Amy R., Doshi, Jalpa A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5774001/ https://www.ncbi.nlm.nih.gov/pubmed/29195016 http://dx.doi.org/10.1002/cam4.1262 |
Ejemplares similares
-
Survival among patients with advanced renal cell carcinoma in the pretargeted versus targeted therapy eras
por: Li, Pengxiang, et al.
Publicado: (2015) -
Treatment utilization patterns of newly initiated oral anticancer agents in a national sample of Medicare beneficiaries
por: Doshi, Jalpa A, et al.
Publicado: (2021) -
Impact of Cost Sharing on Therapeutic Substitution: The Story of Statins in 2006
por: Li, Pengxiang, et al.
Publicado: (2016) -
Impact of Medicare Advantage Prescription Drug Plan Star Ratings on Enrollment before and after Implementation of Quality-Related Bonus Payments in 2012
por: Li, Pengxiang, et al.
Publicado: (2016) -
Use of a medication-based algorithm to identify advanced Parkinson's disease in administrative claims data: Associations with claims-based indicators of disease severity
por: Dahodwala, Nabila, et al.
Publicado: (2020)